Analysts’ Opinions Are Mixed on These Healthcare Stocks: Nanosonics Limited (OtherNNCSF) and Telix Pharmaceuticals Ltd. (OtherTLPPF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2025
0mins
Source: Business Insider
Nanosonics Limited (NNCSF): Analyst Mathieu Chevrier from Citi maintained a Hold rating with a price target of A$4.55, while the consensus remains a Hold with an average target of $2.50, indicating an 8.7% upside from its current price of $2.30.
Telix Pharmaceuticals Ltd. (TLPPF): Analyst John Hester upgraded the stock to Buy with a price target of A$36.00, reflecting a Strong Buy consensus and an 18.4% upside from its recent closing price of $18.90.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
